CrushSCI.com
114.4平均天数
90中位天数
55最短天数
339最长天数
592025发文量

Paper Review Records

全部论文审稿周期

11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

89 天

New ways of patient participation in clinical and translational cancer research

作者
Wiebke Kragl; Jonathan P. Sleeman; Jörg Haier展开收起
作者单位
1. Universitätsmedizin Rostock; 2. Heidelberg University; 3. Medizinische Fakultät Mannheim展开收起
PDF源文件 DOI 网页
100 天

Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study

作者
Alessandro Rizzo; Fernando Sabino Marques Monteiro; Veronica Mollica; Oronzo Brunetti; Elsa Vitale; Angela Monica Sciacovelli; Andrey Soares; Francesco Massari; Matteo Santoni展开收起
作者单位
1. S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy; 2. Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; 3. Oncology and Hematology Department, Hospital Sírio-Libanês, Brasilia, Brazil; 4. Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5. Scientific Directorate, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy; 6. Hospital Israelita Albert Einstein, São Paulo, Brazil; 7. Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; 8. Oncology Unit, Macerata Hospital, Macerata, Italy展开收起
PDF源文件 DOI 网页
157 天

Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment

作者
Xianglin Hu; Huajian Wu; Kewen Hu; Yani Kang; Guoqiang Hua; Mo Cheng; Wangjun Yan; Wending Huang展开收起
作者单位
1. Department of Musculoskeletal Oncology, Spine Tumor Center, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, China; 4. Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China; 5. Research and Early Development (RED) of D1 Medical Technology Company, Shanghai, China展开收起
PDF源文件 DOI 网页
339 天

Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells

作者
Kimberly J. Jasmer; Vinit C. Shanbhag; Kevin Muñoz Forti; Lucas T. Woods; Nikita S. Gudekar; Gary A. Weisman; Michael J. Petris展开收起
作者单位
1. Christopher S. Bond Life Sciences Center 540F, University of Missouri, Columbia, USA; 2. Department of Biochemistry, University of Missouri, Columbia, USA; 3. Department of Ophthalmology, University of Missouri, Columbia, USA展开收起
PDF源文件 DOI 网页
90 天

Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study

作者
Alexander Fabian; Daniel Buergy; Fabian Weykamp; Juliane Hörner-Rieber; Denise Bernhardt; Judit Boda-Heggemann; Montserrat Pazos; Nora Mehrhof; David Kaul; Alicia S. Bicu; Eugenia Vlaskou Badra; Susanne Rogers; Stefan Janssen; Hossein Hemmatazad; Katharina Hintelmann; Eleni Gkika; Tim Lange; Konstantinos Ferentinos; Heiko Karle; Thomas Brunner; Andrea Wittig; Marciana Nona-Duma; Oliver Blanck; David Krug展开收起
作者单位
1. Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany; 2. Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany; 3. Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; 4. Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 5. Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; 6. National Center for Tumor Diseases (NCT), Heidelberg, Germany; 7. Department of Radiation Oncology, University Hospital Düsseldorf, Düsseldorf, Germany; 8. Department of Radiation Oncology, Technical University of Munich, Munich, Germany; 9. Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; 10. Department of Radiation Oncology, Charité—Universitätsmedizin Berlin, Berlin, Germany; 11. Department of Radiation Oncology, Health and Medical University Potsdam, Potsdam, Germany; 12. Department of Radiation Oncology, University Hospital & University of Zurich, Zurich, Switzerland; 13. Radiation Oncology Center KSA-KSB, Kantonsspital Aarau, Aarau, Switzerland; 14. Department of Radiation Oncology, University of Lubeck, Lubeck, Germany; 15. Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany; 16. Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 17. Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 18. Department of Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany; 19. Department of Radiation Oncology, University Hospital Bonn, University of Bonn, Bonn, Germany; 20. Clinic for Radiotherapy, Hannover Medical School, Hannover, Germany; 21. Department of Radiation Oncology, German Oncology Center, European University of Cyprus, Limassol, Cyprus; 22. Department of Radiation Oncology and Radiotherapy, University Medical Center, Mainz, Germany; 23. Department of Radiation Oncology, University Hospital Graz, Graz, Austria; 24. Department of Radiation Oncology, University Hospital Würzburg, Würzburg, Germany; 25. Department of Radiation Oncology, HELIOS Hospital Schwerin, Schwerin, Germany; 26. Department for Human Medicine, MSH Medical School Hamburg, Hamburg, Germany展开收起
PDF源文件 DOI 网页
127 天

Current preclinical models of brain metastasis

作者
Zacharie Drouin; Flavie Lévesque; Korina Mouzakitis; Marilyne Labrie展开收起
作者单位
1. Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada; 2. Centre de Recherche du Centre Hospitalier de l’Université de Sherbrooke (CRCHUS), Sherbrooke, Canada; 3. Institut de Recherche sur le Cancer de l’Université de Sherbrooke (IRCUS), Sherbrooke, Canada展开收起
PDF源文件 DOI 网页

FAQ

CLINICAL & EXPERIMENTAL METASTASIS审稿要多久?

截至2026-11-19,CrushSCI 收录了 CLINICAL & EXPERIMENTAL METASTASIS 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 55 天(Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy,2024-08-06 收稿,2024-09-30 录用),最慢一篇用了 339 天;平均 114.4 天,中位数 90 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。